A company connected to investment interests involving President Donald Trump’s sons has received nearly $40 million in federal contracts for infectious disease screening, raising fresh questions about potential conflicts of interest and the administration’s handling of public money. An investigation by ProPublica found that XpresTest, a subsidiary of XWELL, received federal funding for work involving […]
